8 news items
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
ACIC
ADMA
AEHL
10 May 24
Innovation, Inc. (NASDAQ:AUR) dipped 7.4% to $3.3399
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GRTS
9 May 24
. (NASDAQ:GRTS) is a clinical-stage biotechnology company that aims to develop the world's most potent vaccines. We leverage our innovative vectors and payloads
Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
GRTS
29 Apr 24
of Pennsylvania. "I am thrilled to join the Board of Directors of Gritstone bio, a highly innovative vaccine developer whose novel platforms could
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
GRTS
8 Apr 24
) is a clinical-stage biotechnology company that aims to develop the world's most potent vaccines. We leverage our innovative vectors and payloads
Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
GRTS
1 Apr 24
innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we
athugi54pnljkww2jg d1xzc
GRTS
1 Apr 24
) is a clinical-stage biotechnology company that aims to develop the world's most potent vaccines. We leverage our innovative vectors and payloads
nh30tva84qy495x560pra6jasw87p684ex31w9xazv1ka1z3
GRTS
1 Apr 24
that aims to develop the world's most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack
cnhxv7wpkubsvlh1xqdzxx4i8je887fgtxyqno iuz28mupiv3p
GRTS
5 Mar 24
on leveraging our innovative technologies to drive transformative advances in oncology and infectious disease," said Andrew Allen, M.D., Ph.D., Co-founder
- Prev
- 1
- Next